1 Department of Neurology, University of Colorado Denver, Aurora, CO, USA.
2 Department of Psychiatry, University of Colorado Denver, Aurora, CO, USA.
Palliat Med. 2018 Oct;32(9):1522-1528. doi: 10.1177/0269216318785830. Epub 2018 Jul 17.
There is increasing interest in applying palliative care approaches for patients with Parkinson's disease. Methodological studies are needed to validate palliative care outcome measures for Parkinson's disease to build this evidence base. As many patients with Parkinson's disease have cognitive and/or communication issues, proxy outcome measures may improve the inclusivity and relevance of research.
To assess the validity of proxy caregiver reports for several potential palliative care outcome measures.
A cross-sectional study of Parkinson's disease patients and caregivers completed a battery of outcome measures relevant to palliative care including the Memorial Symptom Assessment Scale, Hospital Anxiety and Depression Scale, Prolonged Grief Questionnaire 12, Parkinson Disease Questionnaire 39, Functional Assessment of Chronic Illness Therapy-Spiritual Wellbeing, and Schwab and England. Intraclass correlation coefficients were used to assess agreement.
SETTING/PARTICIPANTS: A total of 50 Parkinson's disease patient and caregiver dyads recruited at an academic medical center, Veterans Affairs Medical Center, and community support groups.
There was moderate to good agreement for Schwab and England, Parkinson Disease Questionnaire 39 total, and majority of Parkinson Disease Questionnaire 39 subscales; moderate to good agreement for the Hospital Anxiety and Depression Scale, Functional Assessment of Chronic Illness Therapy-Spiritual Wellbeing, Prolonged Grief Questionnaire 12, and Memorial Symptom Assessment Scale; and poor to moderate agreement for the Parkinson Disease Questionnaire 39 stigma, social support, and bodily pain subscales. Caregivers tended to attribute higher symptom severity than patients. We did not detect differences in intraclass correlation coefficient based on cognitive status but patients with advanced illness had significantly lower intraclass correlation coefficients for several outcomes.
Caution is indicated when considering caregiver proxy reporting for most outcomes assessed, particularly in Parkinson's disease patients with advanced disease.
人们对将姑息治疗方法应用于帕金森病患者越来越感兴趣。为了建立这一证据基础,需要进行方法学研究来验证帕金森病姑息治疗结局的测量方法。由于许多帕金森病患者存在认知和/或沟通问题,代理结局测量方法可能会提高研究的包容性和相关性。
评估几种潜在姑息治疗结局测量方法的代理照顾者报告的有效性。
对帕金森病患者及其照顾者进行横断面研究,完成了一系列姑息治疗相关的结局测量,包括纪念症状评估量表、医院焦虑抑郁量表、延长悲伤问卷 12 项、帕金森病问卷 39 项、慢性病治疗-精神健康功能评估量表和 Schwab 和 England 量表。使用组内相关系数评估一致性。
地点/参与者:共纳入 50 对来自学术医疗中心、退伍军人事务医疗中心和社区支持小组的帕金森病患者及其照顾者。
Schwab 和 England、帕金森病问卷 39 总分和多数帕金森病问卷 39 子量表、医院焦虑抑郁量表、慢性病治疗-精神健康功能评估量表、延长悲伤问卷 12 项和纪念症状评估量表具有中度至高度一致性;帕金森病问卷 39 项耻辱感、社会支持和躯体疼痛子量表以及功能评估慢性疾病治疗-精神健康量表具有中度至高度一致性;帕金森病问卷 39 项的社会支持和躯体疼痛子量表具有低度至中度一致性。照顾者倾向于认为患者的症状严重程度更高。我们没有根据认知状态检测到组内相关系数的差异,但病情较重的患者在几个结局的组内相关系数明显较低。
在考虑大多数评估结局的照顾者代理报告时应谨慎,尤其是在病情较重的帕金森病患者中。